MW-401

N/A

Report date: 2025/11/21 17:29:29

Base Information

Drug NameMW-401
Drug Alias NameMW-401MW401
ClassificationOther
Mechanisms of ActionProbable G-protein coupled receptor 75 antagonists
TargetsProbable G-protein coupled receptor 75
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Renal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMwyngil Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMwyngil Therapeutics IncExpert Systems Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2Renal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A